top of page

94% Of Nurse Practitioner Students Say Medical Marijuana Should Be Legalized Across The US

  • Writer: Bob Marley
    Bob Marley
  • Sep 2, 2024
  • 2 min read

A new study finds that while an overwhelming majority of nurse practitioner students favor legalizing medical cannabis and think information about marijuana’s medical benefits should be taught as part of their training, fewer than a third reported actually receiving in-depth education on the topic.

Conducted by two professors at Simmons University’s school of nursing in Boston, the research was published in the September issue of the journal The Nurse Practitioner. Authors looked at survey results of 115 nurse practitioner (NP) students who were asked about medical marijuana.

“Most students (94%) felt that [medical marijuana] should be legalized in all US states,” the research says. “Likewise, 97% felt that MM education should be included in NP program curricula; however, only 30% reported receiving in-depth education on the topic.”

Participants were also asked to identify which of 18 different medical conditions “were approved indications for MM use.”

“Accurate response rate was low,” the research found, “though cancer, pain, cachexia, nausea/vomiting, posttraumatic stress disorder, and epilepsy were identified correctly as indications by more than half of participants.”

In light of the results, and with more and more jurisdictions legalizing medical marijuana, the study says nurse practitioner programs “must evaluate their current curricula and integrate content that addresses the gap in knowledge of MM mechanism of action, indications, and adverse reactions.”

The study comes on the heels of separate research from the nurse practitioner community finding that medical marijuana is associated with reduced prescription drug use and improved well-being and symptom intensity among adults with anxiety, depression, insomnia and chronic pain.

Earlier this year, meanwhile, the American Nurses Association (ANA) cheered the U.S. Department of Health and Human Services’s (HHS) recommendation to move marijuana to Schedule III, calling the action “a positive step toward developing an evidence-based approach for marijuana and related-cannabinoids use in disease and symptom management.”

ANA—which represents more than 5 million nurses across the U.S.—also recently recognized cannabis as a nursing specialty practice area.

“This recognition highlights the essential role and special contribution of cannabis nurses to the health care system and promotes enhanced integration of cannabis therapies for health care consumers across diverse health care settings,” ANA President Jennifer Mensik Kennedy said at the time.

Feds Fund Research On How Psychedelics Can Treat Meth Addiction With New $2.4 Million Grant

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page